Does size matter? Tumor density as a predictor of clinically significant prostate cancer on MRI-targeted transperineal prostate biopsy.
PURPOSE Prior studies of tumor burden as a predictor of clinically significant prostate cancer (csPCa) consist of per-patient analyses or are limited by imprecise size measurements. This study evaluates tumor density (TD) as a lesion-level predictor of csPCa on magnetic resonance imaging (MRI)-targeted biopsy. METHOD...